BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34140620)

  • 1. HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice.
    Ohno Y; Ohshima S; Miyamoto A; Kametani F; Ito R; Tsuda B; Kasama Y; Nakada S; Kashiwagi H; Seki T; Yasuda A; Ando K; Ito M; Tokuda Y; Kametani Y
    Sci Rep; 2021 Jun; 11(1):12798. PubMed ID: 34140620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
    Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
    PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg mice.
    Seki T; Miyamoto A; Ohshima S; Ohno Y; Yasuda A; Tokuda Y; Ando K; Kametani Y
    Biosci Trends; 2018 Jul; 12(3):247-256. PubMed ID: 29806632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
    Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
    Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
    Steinsvik TE; Gaarder PI; Aaberge IS; Løvik
    Scand J Immunol; 1995 Dec; 42(6):607-16. PubMed ID: 8552984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice.
    Hanazawa A; Ito R; Katano I; Kawai K; Goto M; Suemizu H; Kawakami Y; Ito M; Takahashi T
    Front Immunol; 2018; 9():152. PubMed ID: 29456539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S; Smith FO; Ochs HD
    J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
    Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides.
    Chargui J; Dye D; Blomberg J; Desgranges C; Touraine JL
    J Immunol Methods; 1995 Apr; 181(1):91-100. PubMed ID: 7730668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
    Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
    Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice.
    Xie Y; Wu J; Xu A; Ahmeqd S; Sami A; Chibbar R; Freywald A; Zheng C; Xiang J
    Vaccine; 2018 Mar; 36(11):1414-1422. PubMed ID: 29415817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced
    Garaud S; Zayakin P; Buisseret L; Rulle U; Silina K; de Wind A; Van den Eyden G; Larsimont D; Willard-Gallo K; Linē A
    Front Immunol; 2018; 9():2660. PubMed ID: 30515157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.
    Garaud S; Buisseret L; Solinas C; Gu-Trantien C; de Wind A; Van den Eynden G; Naveaux C; Lodewyckx JN; Boisson A; Duvillier H; Craciun L; Ameye L; Veys I; Paesmans M; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
    JCI Insight; 2019 Aug; 5(18):. PubMed ID: 31408436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
    Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
    Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
    Snyder NK; Kramer CM; Dooley RK; Holsapple MP
    Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
    [TBL] [